Skip to Main Content

Leadership

The people behind the science.

Meet the experts behind our products and work directly alongside the team for your evaluation.

Leadership

Scott E. Deeter

Scott E. Deeter

Founder and Chief Executive Officer

Mr. Deeter is InVitria’s Founder and CEO.  Previously, he started and led a joint venture between Cargill and F. Hoffmann-La Roche that commercialized several novel pharmaceutical ingredients derived from plants.  Scott has served as President and CEO of CyberCrop and was a member of the Technology and Life Sciences Group of Salomon Brothers.  He is a graduate of the University of Kansas, University of Chicago, and London School of Economics and Political Science.

Ron Backman

Ron Backman

Vice President, Quality

Mr. Backman leads InVitria’s Quality Assurance and Quality Control. He has over 23 years of biopharmaceutical Quality experience with increasing responsibilities throughout his career. He joined the company after managing Product Quality, Stability and Microbiology services at KBI Biopharma, a global contract development & manufacturing organization. Prior to KBI Biopharma he managed Quality Control and Support at Diosynth Biotechnology. Ron started his career in the Quality department of Boehringer Ingelheim. He received his Bachelor of Science in Biology from Kansas State University.

Jacob Weber, Ph.D.

Jacob Weber, Ph.D.

Vice President, Process Development

Dr. Weber leads the scale-up of new methods for processing and purifying recombinant proteins in a sustainable and reliable way. Prior to working with the Company, Dr. Weber was a Quality Control Engineer for Park Aerospace Technologies Corp. Dr. Weber received a Ph.D. in Biochemistry from Kansas State University and a  Bachelor of Arts in Natural Science from Bethel College.

Mark Stathos, Ph.D.

Mark Stathos, Ph.D.

Director, Cell Biology

Dr. Stathos leads InVitria’s research and development lab based in Junction City, Kansas, provides technical support to customers, publishes application notes, and supports new product development. His team’s research focuses on optimizing the performance of InVitria’s products in a variety of therapeutically relevant applications including cryopreservation, cell expansion, virus stabilization, diagnostics, and assisted reproductive technology. Prior to InVitria, Dr. Stathos worked as a research scientist at Artisan Biotechnologies, an allogeneic CAR-T cell therapy company. Dr. Stathos holds a PhD in Bioengineering from the Georgia Institute of Technology.

Commercial & applications

Marcus Curl

Marcus Curl

Vice President, Product Applications

Mr. Curl leads the Product Applications team working with leading developers in cell and gene therapy and vaccines to help them improve their workflows by implementing recombinant, scalable and sustainable solutions for biomanufacturing and final formulation. He has been instrumental in establishing the customer opportunity pipeline and has account management responsibilities in Europe and UK.  His responsibilities are global, giving him a unique perspective valued by customers. Mr. Curl received his B.S. in Biology from Pitzer College, one of the Claremont Colleges.

Elliott Renft

Elliott Renft

Director, Product Applications North America

Mr. Renft  oversees Product Applications for accounts in North America. He works with customers to optimize workflows using recombinant, scalable and sustainable technologies. He facilitates the implementation of InVitria products in cell and gene therapies, vaccines, medical devices, and biologic formulation. Before joining InVitria, he had responsibility for commercial activities within the Interventional division of Becton, Dickinson and Company. There he worked with clinicians to deliver bio surgical devices for patients. Mr. Renft received his Bachelor of Science in Molecular, Cellular, and Developmental Biology with a Minor in Business from the University of Kansas.

Jake Hanks

Jake Hanks

Business Development Director

Mr. Hanks serves as Business Development Director, supporting InVitria’s key accounts. He focuses on developing strategic partnerships to support customers through evaluation, qualification, regulatory approval and scale-up. He works closely with the Product Applications Team. Previously, Mr. Hanks worked for BOK Financial as a member of the commercial banking group. He also served as a Business Development Manager for Synergy One lending. Mr. Hanks received his Bachelor of Science and his MBA from the University of Tulsa while a member of their Division 1 football team.

Careers

Build the platform with us.

The team that takes animal-derived components out of biomanufacturing is growing across process development, quality, and commercial.